vs-505
Botanicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT02469467)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vs-505
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04551300 | Phase 2 | Oct 13, 2020 | Alebund Pharmaceuticals |
| NCT02469467 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2015 | KDL Inc., LCR Clinical Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alebund Pharmaceuticals | For profit | 1 | 1 | 1 | 2020 |
| KDL Inc. | For profit | 1 | 1 | 1 | 2015 |
| LCR Clinical Research | For profit | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1